AWMSG

(redirected from All Wales Medicines Strategy Group)
AcronymDefinition
AWMSGAll Wales Medicines Strategy Group (UK)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
A Welsh Government spokesman said: "We are guided by the recommendations of the National Institute for Health and Care Excellence (NICE) and the All Wales Medicines Strategy Group (AWMSG) about which medicines should be available on the NHS in Wales.
The All Wales Medicines Strategy Group (AWMSG) has recommended Pfizer's (NYSE: PFE) Somavert (pegvisomant) as an option for routine use on the NHS in Wales, Pharma Times reported on Friday.
The All Wales Medicines Strategy Group (AWMSG) has issued guidance stating that Novo Nordisk's insulin, also known as Tresiba, would now be available to healthcare professionals.
Dr Matthew Makin, chief of staff of the Cancer Clinical Programme Group, said: "If a drug is approved by NICE and the All Wales Medicines Strategy Group, then such drugs are used as standard treatment.
Doug Naysmith (Lab Bristol North West) told Ministers: 'The All Wales Medicines Strategy Group recommended the use of this drug in NHS Wales earlier this month, pending ministerial ratification.
The All Wales Medicines Strategy Group (AWMSG) has approved selexipag, a new twice daily tablet, for patients with pulmonary arterial hypertension (PAH).
Yesterday their battle was won after Health and Social Services Minister Mark Drakeford announced he has approved a recommendation from the All Wales Medicines Strategy Group (AWMSG) that Vimizim should be available in Wales.
Speaking at the All Wales Medicines Strategy Group tenth anniversary conference, Griffiths said: "I feel strongly a Cancer Drugs Fund would not be in the best interests of people in Wales."
"All new medicines that are deemed clinically and cost effective by Nice or the All Wales Medicines Strategy Group are provided on the NHS.
The All Wales Medicines Strategy Group has accepted Briviact, also known as brivaracetam, for use within NHS Wales as an add-on treatment for partial onset seizures.
Cetuximab will be available as an option for the first-line treatment of patients with certain types of colorectal cancer following a positive recommendation by the All Wales Medicines Strategy Group (AWMSG).